| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.00037 | 1 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.00049 | 1 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.00066 | 1 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.00026 | 1 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.00038 | 1 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.00024 | 1 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.00044 | 1 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.00043 | 1 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.00021 | 1 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.00019 | 1 |